NCT03904862 2025-10-30
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Pediatric Brain Tumor Consortium
Phase 1/2 Terminated
Pediatric Brain Tumor Consortium
European Organisation for Research and Treatment of Cancer - EORTC
St. Jude Children's Research Hospital
Novartis